End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-05 EDT
|
5-day change
|
1st Jan Change
|
28.08
CNY
|
+0.47%
|
|
-0.07%
|
-10.52%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,369
|
13,786
|
14,481
|
25,203
|
18,575
|
21,312
|
Enterprise Value (EV)
1 |
6,586
|
14,149
|
14,996
|
25,387
|
18,670
|
21,834
|
P/E ratio
|
12.7
x
|
45.4
x
|
61.7
x
|
34.4
x
|
80.4
x
|
165
x
|
Yield
|
1.63%
|
0.25%
|
0.62%
|
0.59%
|
0.22%
|
0.16%
|
Capitalization / Revenue
|
1.67
x
|
3.65
x
|
4.09
x
|
5.19
x
|
4.33
x
|
5.81
x
|
EV / Revenue
|
1.72
x
|
3.75
x
|
4.24
x
|
5.23
x
|
4.35
x
|
5.95
x
|
EV / EBITDA
|
9.51
x
|
25
x
|
27.5
x
|
24.3
x
|
49
x
|
58.1
x
|
EV / FCF
|
21.6
x
|
-101
x
|
-94.6
x
|
56.2
x
|
90.4
x
|
-49
x
|
FCF Yield
|
4.63%
|
-0.99%
|
-1.06%
|
1.78%
|
1.11%
|
-2.04%
|
Price to Book
|
2.63
x
|
5.14
x
|
4.98
x
|
7.31
x
|
5.14
x
|
5.76
x
|
Nbr of stocks (in thousands)
|
690,000
|
690,000
|
689,890
|
679,156
|
679,156
|
679,156
|
Reference price
2 |
9.230
|
19.98
|
20.99
|
37.11
|
27.35
|
31.38
|
Announcement Date
|
19-04-15
|
20-04-06
|
21-04-20
|
22-04-27
|
23-04-27
|
24-03-13
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,820
|
3,774
|
3,536
|
4,859
|
4,292
|
3,668
|
EBITDA
1 |
692.3
|
565.6
|
545.5
|
1,044
|
380.7
|
376
|
EBIT
1 |
536.6
|
400.7
|
374.5
|
877.8
|
210
|
187
|
Operating Margin
|
14.05%
|
10.62%
|
10.59%
|
18.07%
|
4.89%
|
5.1%
|
Earnings before Tax (EBT)
1 |
617.8
|
361.1
|
263.5
|
820.1
|
229.2
|
151.8
|
Net income
1 |
503.3
|
306.7
|
236.2
|
732.3
|
229.8
|
128.1
|
Net margin
|
13.17%
|
8.13%
|
6.68%
|
15.07%
|
5.35%
|
3.49%
|
EPS
2 |
0.7281
|
0.4400
|
0.3400
|
1.080
|
0.3400
|
0.1900
|
Free Cash Flow
1 |
304.7
|
-140.6
|
-158.5
|
452
|
206.5
|
-445.6
|
FCF margin
|
7.98%
|
-3.73%
|
-4.48%
|
9.3%
|
4.81%
|
-12.15%
|
FCF Conversion (EBITDA)
|
44.01%
|
-
|
-
|
43.31%
|
54.24%
|
-
|
FCF Conversion (Net income)
|
60.54%
|
-
|
-
|
61.72%
|
89.87%
|
-
|
Dividend per Share
2 |
0.1500
|
0.0500
|
0.1300
|
0.2200
|
0.0600
|
0.0500
|
Announcement Date
|
19-04-15
|
20-04-06
|
21-04-20
|
22-04-27
|
23-04-27
|
24-03-13
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
217
|
363
|
515
|
184
|
95.3
|
522
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.3133
x
|
0.6423
x
|
0.9447
x
|
0.176
x
|
0.2504
x
|
1.389
x
|
Free Cash Flow
1 |
305
|
-141
|
-158
|
452
|
206
|
-446
|
ROE (net income / shareholders' equity)
|
20.4%
|
12%
|
7.67%
|
20.4%
|
5.24%
|
2.66%
|
ROA (Net income/ Total Assets)
|
8.36%
|
5.78%
|
5.05%
|
10.9%
|
2.53%
|
2.1%
|
Assets
1 |
6,021
|
5,309
|
4,681
|
6,727
|
9,073
|
6,107
|
Book Value Per Share
2 |
3.510
|
3.890
|
4.220
|
5.080
|
5.320
|
5.450
|
Cash Flow per Share
2 |
0.4100
|
0.4500
|
0.5500
|
0.7900
|
0.6300
|
1.050
|
Capex
1 |
73.3
|
96.8
|
164
|
38.2
|
64.9
|
261
|
Capex / Sales
|
1.92%
|
2.57%
|
4.64%
|
0.79%
|
1.51%
|
7.13%
|
Announcement Date
|
19-04-15
|
20-04-06
|
21-04-20
|
22-04-27
|
23-04-27
|
24-03-13
|
|
1st Jan change
|
Capi.
|
---|
| -10.52% | 2.62B | | +3.28% | 102B | | -2.28% | 65.53B | | +46.19% | 41.76B | | +19.68% | 38.66B | | +4.90% | 32.28B | | +9.53% | 19.57B | | +15.64% | 16.77B | | +21.26% | 15.08B | | +11.59% | 14.83B |
Other Commodity Chemicals
|